Skip to content

Cyanoacrylate With or Without Suture?

Does Cyanoacrylate Require Supportive Suturing to Reduce Seconder Bleeding and Stabilizing Biomaterial at the Donor Site?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06083259
Enrollment
37
Registered
2023-10-13
Start date
2023-12-05
Completion date
2024-08-16
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Heal

Brief summary

An epithelialized gingival graft will be harvested from the palate for the treatment of various mucogingival deformities. The donor site will be treated with either a combination of a collagen sponge and cyanoacrylate or a collagen sponge, cyanoacrylate, and suspending sutures. Intraoperatively, measurements will be taken for palatal tissue thickness, graft dimensions, working time, and primary bleeding time. Data regarding pain perception will be gauged using a visual analog scale, and the number of analgesics, secondary bleeding, epithelization level, and color match will be assessed prospectively. These outcomes will be evaluated on the first 7 days and subsequently on the 14th, 21st, and 28th days. Patient-reported outcomes will be recorded using the Oral Health Impact Profile-14 questionnaire.

Interventions

The donor site will be closed both with gelatin sponge +Cyanoacrylate (Spongostan®, Ethicon, USA)+ supporting sutures (control group)

PROCEDUREGelatin sponge stabilization with cyanoacrylate

Seconder The donor site will be closed both with gelatin sponge +Cyanoacrylate (Spongostan®, USA) (test group)

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion Criteria: * age ≥18; * mucogingival surgical treatment indication that needs connective tissue graft in the anterior mandible; * stable periodontium after phase I therapy; * full-mouth plaque and bleeding scores \<15%

Exclusion criteria

* previous palatal harvesting history; * unstable endodontic conditions; * tooth mobility at the surgical site; * systemic disease; * pregnancy; * use of medications with potential adverse effects on periodontal tissues

Design outcomes

Primary

MeasureTime frameDescription
Donor site pain perceptioneveryday in first weekPatients score their daily donor site pain perception using visual analog score level by giving numbers from 0 to 10 according to the visual analog scale (0: no pain, 1: minimal pain, 10: severe pain)
Secondary bleeding timeduring first weekPatients will record presence or absence of secondary bleeding (presence=1 or absence=0).

Secondary

MeasureTime frameDescription
Graft thicknessduring surgeryDimensions will be measured during surgery by clinician using Michigan O probe (will be reported in mm)
Working timeduring surgeryHarvesting process will be recorded by an blinded research assistant
Quantity of analgesicsfirst weekPatients recorded the quantity of analgesics taken will be reported as quantity of pill
Graft heightduring surgeryDimensions will be measured during surgery by clinician using Michigan O probe (will be reported in mm)
Color matchfirst week, second week, third week, fourth week.Color match with the adjacent tissue was determined by researcher using a Visual Analog Pain Scale scale (0: absence of harmony, 10: excellent harmony)
Epithelization levelfirst week, second week, third week, fourth week.Epithelization level was scored by researcher as none, partial or full epithelization by means of bubble formation after dripping hydrogen peroxide (3%) to the wound surface.
The Oral Health Impact Profile-14 is a questionnaire that measures how oral disorders impact a patient's quality of life.first weekThe questionnaire has 14 items with answers rated on a 5-point Likert scale (from 1 = never to 5 = very often) to indicate a level of different problems related to oral health
Sensation lossfirst week, second week , third week, fourth week.Sensation loss will be scored by the help of clinician comparing with the symmetrical side an will be recorded as no-loss, medium loss or severe loss
Graft widthduring surgeryDimensions will be measured during surgery by clinician using Michigan O probe.(will be reported in mm)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026